Hamostaseologie 1986; 06(02): 99-101
DOI: 10.1055/s-0038-1655144
Originalarbeiten
Schattauer GmbH

Die Funktion der Thrombozyten bei der Blutgerinnung

E F Lüscher
1   Theodor-Kocher-Institut der Universität Bern
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
25. Juni 2018 (online)

 

 
  • LITERATUR

  • 1 Baumgartner H R. The subendothelial surface and thrombosis. In: Thrombosis: Pathogenesis and Clinical Trials. Trans. IV Int. Congr. on Thrombosis and Haemostasis. Deutsch E, Brinkhous K M, Lechner K, Hinnom S. (Eds). Schattauer; Stuttgart New York: 1974: 91-106.
  • 2 Bertina R M, Broekmans A W, van der Linden I K, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5.
  • 3 Bevers E M, Comfurius P, Hemker H C, Zwaal R F A. On the clot promoting activity of human platelets in a one-stage prothrombinase assay. Haemostasis 1982; 12: 268-74.
  • 4 Bevers E M, Comfurius P, Hemker H C, Zwaal R F A. On the procoagulant activity of platelets stimulated by collagen and thrombin. Thromb Res 1984; 33: 553-4.
  • 5 Born G V R, Richardson P D. Activation time of blood platelets. J Membr Biol 1980; 57: 87-90.
  • 6 Born G V. R, Görög P, Kratzer M A A. Aggregation of platelets in damaged vessels. Phil Trans R Soc Lond 1981; B294: 241-50.
  • 7 Broekmans A W, Bertina R M, ReinaldaPoot J, Engesser L, Muller H P, Leeuw J A, Michiels J J, Brommer E J P, Briët E. Hereditary protein S deficiency and venous thromboembolism. A study in three Dutch families. Thromb Haemostas 1985; 53: 273-7.
  • 8 Brox J H O, Østerud B. Evidence for appearance of »lysis-independent« procoagulant activities in collagen or thrombin stimulated platelets. Thromb Res 1983; 30: 449-58.
  • 9 Brox J H O, Østerud B. Platelet factor 3 assay and the availability of platelet factor 3 in collagen or thrombin stimulated platelets. Thromb Res 1984; 33: 555.
  • 10 Chesney C M, Pifer D D, Colman R W. Factor V coagulant activity of human platelets generated by collagen. Circulation 1978; 58: 209.
  • 11 Dahlbäck B, Stenflo J. The activation of prothrombin by platelet-bound factor Xa. Eur J Biochem 1980; 104: 549-57.
  • 12 Dahlbäck B, Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa. Eur J Biochem 1980; 107: 331-5.
  • 13 Ittyerah T R, Rawala R, Colman R W. Factor V binding to human platelets: The role of divalent cations and of platelet preparatory methods. Thromb Res 1982; 26: 59-71.
  • 14 Joist J H, Niewiarowski S. Retention of fibrin stabilizing factor during the platelet release reaction and clot retraction. Thromb Diathes Haemorrh 1973; 29: 679-83.
  • 15 Kane W H, Lindhout M J, Jackson C W, Majerus P W. Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem 1980; 255: 1170-4.
  • 16 Kisiel W. Human plasma protein C. Isolation, characterization and mechanism of activation by alpha-thrombin. J Clin Invest 1979; 63: 761.
  • 17 Lipscomb M S, Walsh P N. Human platelets and factor XI. Localization in platelet membranes of factor Xl-like activity and its distinction from plasma factor XI. J Clin Invest 1979; 63: 1006-14.
  • 18 Loeliger E A. Pers. Mitteilung.
  • 19 Lüscher E F. Ein fibrinstabilisierender Faktor aus Thrombozyten. Schweiz Med Wschr 1957; 87: 1220-1.
  • 20 McDonald R I, Shepro D, Rosenthal M, Booyse F M. Properties of cultured endothelial cells. Ser Haemat 1973; 06: 469-78.
  • 21 Morawitz P. Die Chemie der Blutgerinnung. Ergebn Physiol 1905; 04: 307-22.
  • 22 Pearson J D, Gordon J L. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature Lond 1979; 281: 384-6.
  • 23 Salem H H, Maruyama I, Ishii H, Majerus P W. Isolation and characterization of thrombomodulin from human platelets. J Biol Chem 1984; 259: 12246-51.
  • 24 Schwarz M L, Pizzo V, Hill R L, McKee P A. Human factor XIII from plasma and platelets. J Biol Chem 1973; 248: 1359-407.
  • 25 Sewerin K, Andersson L O. Binding of native and thrombin activated factor VIII to platelets. Thromb Res 1983; 31: 695-706.
  • 26 Stenflo J. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355.
  • 27 Suehiro A, Kakishita E, Nagai K. The role of platelet hyperfunction in thrombus formation in hyperlipidemia. Thromb Res 1982; 25: 331-9.
  • 28 Tuszynski G P, Walsh P N. Platelet membrane factor XI substitutes for plasma factor XI. Thromb Haemostas 1979; 42: 36.
  • 29 Walsh P N. Albumin density gradient separation and washing of platelets and the study of platelet coagulant activities. Br J Haemat 1972; 22: 205-17.
  • 30 Walsh P N, Griffin J H. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood 1981; 57: 106-18.
  • 31 van de Waart P, Hemker H C, Lindhout T. Interaction of prothrombin with factor Va-phospholipid complexes. Biochemistry 1984; 23: 2838-42.
  • 32 Wurzinger L J, Opitz R, Blasberg P, Schmid-Schönbein H. Platelet and coagulation parameters following millisecond exposure to laminar shear stress. Thromb Haemostas 1985; 54: 381-6.
  • 33 Zwaal R F A, Hemker H C. Blood cell membranes and haemostasis. Haemostasis 1982; 11: 12-39.
  • 34 Zwaal R F A, Comfurius P, Hemker H C, Bevers E M. The inhibition of platelet prothrombinase activity by prostacyclin. Haemostasis 1984; 14: 320-4.
  • 35 Zwaal R F A, Comfurius P, van Deenen L L M. Membrane asymmetry and blood coagulation. Nature Lond 1979; 268: 358-60.